SCHEMBL23770443

SCHEMBL23770443

Cc1ccccc1-c1nc(NS)ccc1C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.37
CYP3A4 P08684 4/20 0.37
AR P10275 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TRPA1 O75762 2/20 0.36
HSD11B1 P28845 1/20 0.36
HTT P42858 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
PTPN1 P18031 1/20 0.35
SDHB P21912 1/20 0.35
ADORA2A P29274 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
S1PR1 P21453 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29464851 0.77 HSD11B1 (0.40) CYP1A2CYP3A4ARTRPA1HSD11B1
SCHEMBL19968788 0.77 HSD11B1 (0.40) CYP1A2CYP3A4ARTRPA1HSD11B1
SCHEMBL19968786 0.77 BACE1 (0.44) ARALDH1A1TRPA1HSD11B1HTT
SCHEMBL23770551 0.75 PTPN1 (0.36) CYP1A2CYP3A4ARCYP2C19ALDH1A1
SCHEMBL23770815 0.74 CYP1A2 (0.39) CYP1A2CYP3A4ARCYP2C19ALDH1A1
SCHEMBL23770399 0.74 PTPN1 (0.35) CYP1A2CYP3A4ARCYP2C19ALDH1A1
SCHEMBL19927705 0.73 SCN1A (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1HSD11B1
SCHEMBL29464874 0.73 SCN1A (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1HSD11B1
SCHEMBL19951335 0.72 SYK (0.42) CYP1A2CYP3A4CYP2C19ALDH1A1HSD11B1
SCHEMBL19925735 0.72 PTGS2 (0.35) CYP1A2CYP3A4CYP2C19ALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed